Abcellera Biologics is trading 4.16% up at $10.89 as broader markets rally after inflation data.
- The S&P 500, Nasdaq Composite, and Dow Jones are each up more than 0.9%, supporting risk-on sentiment.
- No new company-specific announcement was identified for September 11, 2026; recent conference and offering news are earlier catalysts.